Metabolic & Cardiometabolic
bariatric surgery decreases cancer incidence
In plain terms: Does bariatric surgery reduce cancer incidence?
Leans support Metabolic & Cardiometabolic 🔬 Includes disconfirming
Part of: 🩺 bariatric / metabolic surgery
RefutedContestedStrong support
consensus score 0.59
Yes for obesity-associated cancers—large cohorts and metas show ~30-40% lower incidence, strongest in women/hormone-related cancers; evidence is observational.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
15 support 1 contradict 1 tested null 7 mixed · 24 sources, 15 independent groups
The evidence (24)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Langegård E et al 2026 · study_type: observational | observational | mixed | high | SOS study, 2596 women followed median 23.9y; 135 breast cancer cases (77 control, 58 surgery). Surgery lowered breast cancer incidence in FTO risk-allele carriers (adjusted HR 0.53, 95% CI 0.34-0.83) but not in non-carriers (HR 1.19, 95% CI |
| Ghusn 2026 · Obes Surg | observational | supports | moderate | Propensity-matched multicenter analysis found metabolic/bariatric surgery associated with lower incident malignancy vs dietary counseling. |
| Leijonmarck W et al 2026 · study_type: observational | observational | contradicts | moderate | Nordic population cohort, 109,097 bariatric surgeries (82,394 gastric bypass) over up to 44 years follow-up; 46 patients developed gastric non-cardia adenocarcinoma. Gastric bypass associated with increased adenocarcinoma risk in the exclud |
| Sjöholm K et al 2026 · study_type: observational | observational | mixed | high | SOS post-hoc analysis, 2007 surgery patients vs 2040 controls, median follow-up ~26-27 years. Bariatric surgery lowered overall cancer incidence in women (HRadj 0.78, 95% CI 0.67-0.90) and especially female-specific cancers (HRadj 0.60), bu |
| Ipaye 2025 · Diabetes Obes Metab | observational | supports | moderate | Real-world cohort in type 2 diabetes found weight-loss interventions including bariatric surgery associated with fewer obesity-associated cancers. |
| Abdulmajeed 2025 · Biomol Biomed | observational | supports | moderate | Target-trial-emulation cohort (124,780 adults) found bariatric surgery associated with roughly halved cancer hazard (HR 0.49). |
| Aminian 2022 · JAMA | observational | supports | high | SPLENDID matched cohort (30k): surgery cut obesity-associated cancer incidence (HR 0.68) and cancer mortality (HR 0.52). |
| Hu C et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | Meta-analysis of 10 cohort studies, 3,929,395 participants. Bariatric surgery associated with significantly lower gallbladder cancer incidence (95% CI 0.35-0.90), with subgroup HRs 0.45-0.6 depending on study size/quality. |
| Rzeska W et al 2026 · study_type: observational | observational | supports | moderate | Narrative review on endometrial carcinogenesis stating bariatric surgery 'offers the strongest human evidence' that durable metabolic correction substantially reduces endometrial cancer incidence, in contrast to pharmacologic interventions |
| El Ghazal N et al 2026 · study_type: observational | observational | supports | low | Narrative review stating that bariatric-surgery-induced weight loss and hormonal restoration reduces the incidence and mortality of endometrial cancer, among other benefits to women's reproductive health. |
| Jalmood R et al 2026 · study_type: meta-analysis | meta-analysis | supports | moderate | Meta-analysis of 8 studies, 793,197 women (140,880 surgery, 652,317 non-surgical). Bariatric surgery associated with lower breast cancer incidence (pooled HR 0.61, 95% CI 0.46-0.80), in both pre- and postmenopausal women. |
| Lim JS et al 2026 · study_type: observational | observational | supports | low | Narrative synthesis of meta-analyses and cohort studies concluding that intentional weight loss via bariatric surgery, GLP-1 RAs, or lifestyle can reduce overall or site-specific cancer incidence, while stating estimates are heterogeneous a |
| Shen S et al 2026 · study_type: observational | observational | supports | moderate | Narrative translational review citing observational data: patients losing >10% body weight via bariatric procedures (n=30,318) had modest reductions in obesity-associated cancer incidence (absolute change -0.02% to -0.5%). |
| Liu H et al 2026 · study_type: observational | observational | mixed | moderate | Narrative synthesis reporting that RYGB is associated with increased long-term colorectal cancer risk (HR 1.55 at 10-14 years) while sleeve gastrectomy shows no equivalent elevation, though follow-up durations differ (4.5 vs 8.5 years). |
| Sjostrom 2014 · JAMA | observational | supports | moderate | SOS cohort: lower cancer incidence with surgery, notably in women—an early signal underpinning later cohorts. |
| Ruffini 2025 · Int J Gynaecol Obstet | meta-analysis | supports | moderate | Weight-loss measures (incl. surgery) reduce endometrial cancer risk—hormone-related cancer signal strongest. |
| Stenberg 2025 · Obesity (Silver Spring) | observational | mixed | moderate | Nationwide matched cohort found overall cancer risk after bariatric surgery not lower than the general population, with site-specific variation. |
| Wilson 2023 · Surg Obes Relat Dis | observational | supports | moderate | SPLENDID review: substantial sustained weight loss reduces cancer incidence/mortality, consistent with prior cohorts. |
| Clifford JT et al 2025 · study_type: meta-analysis | meta-analysis | mixed | moderate | Meta-analysis of 14 studies, 2,288,003 patients. Bariatric surgery reduced overall breast cancer incidence (RR 0.58, 95% CI 0.46-0.72), but subgroup analyses found no statistically significant reduction in premenopausal (RR 0.88) or postmen |
| Reytor-González C et al 2026 · study_type: observational | observational | supports | moderate | Narrative review synthesizing epidemiological evidence that bariatric surgery is associated with reduced overall cancer risk and cancer-related mortality for obesity-linked malignancies, while noting the benefit is less consistent for color |
| Wolff Sagy 2025 · EClinicalMedicine | observational | tested-null | moderate | Retrospective cohort found bariatric surgery associated with lower obesity-related cancer incidence than first-generation GLP-1 RAs. |
| Schauer 2023 · Surg Obes Relat Dis | observational | mixed | moderate | Review: association robust for obesity-related cancers but confounding and site-specific heterogeneity caution against overgeneralizing. |
| Chen 2024 · Surg Obes Relat Dis | meta-analysis | supports | high | 33-cohort meta: significantly lower overall and obesity-related cancer incidence after bariatric surgery. |
| Chong KH et al 2026 · study_type: observational | observational | mixed | moderate | TriNetX cohort, 4,439,072 women with severe obesity. Early sleeve gastrectomy (≤6mo) reduced 5-year breast cancer incidence (RR 0.799) and gynecologic cancer (RR 0.490), but delayed surgery (1-3y) was associated with increased breast cancer |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.